Latest news
Price to earnings forward of Saluda Medical Inc CHESS Depository Interest – ASX:SLD - TradingViewTradingView · Thu, 06 Aug 2026 21:40:02 GMTSLD: Q4 revenue surged 43% year-over-year, with new FDA-approved products expanding market reach by 30% - TradingViewTradingView · Wed, 29 Jul 2026 23:59:04 GMTSLD: Revenue up 28% to $90.2M, driven by US and international growth and new FDA product approval - TradingViewTradingView · Tue, 28 Jul 2026 23:09:53 GMTSLD: FY26 revenue up 28% YoY, Q4 up 43%, with new FDA-approved paddle lead expanding market reach - TradingViewTradingView · Tue, 28 Jul 2026 23:09:52 GMT